Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025)
Siga Technologies (SIGA) posted Depreciation & Amortization (CF) of $141795.0 for Q3 2025, down 18.65% on a QoQ basis from $174294.0 in Q2 2025, and up 10.45% year-over-year from $128382.0 in Q3 2024.
Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Siga Technologies' Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $141795.0 for Q3 2025.
- Quarterly Depreciation & Amortization (CF) rose 10.45% year-over-year to $141795.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $416089.0 (down 16.78% YoY) and the FY2024 annual result came in at $500000.0, down 7.11% from the prior year.
- Depreciation & Amortization (CF) was $141795.0 for Q3 2025 at Siga Technologies, down from $174294.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $200000.0 in Q2 2021 and bottomed at $92308.0 in Q4 2024.
- A 5-year average of $130106.6 and a median of $130203.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) sank 35.64% — and 2024, when it jumped 38.47%.
- Siga Technologies' Depreciation & Amortization (CF) stood at $100000.0 in 2021, then soared by 31.2% to $131203.0 in 2022, then increased by 4.87% to $137591.0 in 2023, then tumbled by 32.91% to $92308.0 in 2024, then jumped by 53.61% to $141795.0 in 2025.
- Business Quant data shows SIGA's Depreciation & Amortization (CF) at $141795.0 in Q3 2025, $174294.0 in Q2 2025, and $100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 141,795.00 |
| Sep 30, 2025 | 141,795.00 |
| Jun 30, 2025 | 174,294.00 |
| Jun 30, 2025 | 174,294.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 92,308.00 |
| Dec 31, 2024 | 92,308.00 |
| Sep 30, 2024 | 128,382.00 |
| Sep 30, 2024 | 128,382.00 |
| Jun 30, 2024 | 140,839.00 |
| Jun 30, 2024 | 140,839.00 |
| Mar 31, 2024 | 138,471.00 |
| Mar 31, 2024 | 138,471.00 |
| Dec 31, 2023 | 137,591.00 |
| Dec 31, 2023 | 137,591.00 |
| Sep 30, 2023 | 135,924.00 |
| Sep 30, 2023 | 135,924.00 |
| Jun 30, 2023 | 164,778.00 |
| Jun 30, 2023 | 164,778.00 |